Reyon Pharmaceutical Co Ltd (102460) — Free Cash Flow Generation Index
Reyon Pharmaceutical Co Ltd (102460) has a Free Cash Flow Generation Index of -0.76x as of March 2025. Free cash flow of ₩-1.83 Billion represents -1% of operating cash flow (₩2.41 Billion). Read Reyon Pharmaceutical Co Ltd (102460) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Reyon Pharmaceutical Co Ltd Free Cash Flow Generation Index (2008–2023)
Historical FCF Generation Index trend for Reyon Pharmaceutical Co Ltd across 11 annual periods. Explore Reyon Pharmaceutical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Reyon Pharmaceutical Co Ltd (2008–2023)
Year-by-year Free Cash Flow Generation Index for Reyon Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 102460 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -2.34x | ₩-20.23 Billion | ₩8.65 Billion | ₩28.87 Billion | ▲ +62.5% |
| 2022 | -6.23x | ₩-54.40 Billion | ₩8.73 Billion | ₩63.13 Billion | ▲ +30.9% |
| 2021 | -9.01x | ₩-105.31 Billion | ₩11.68 Billion | ₩116.98 Billion | ▲ +13.1% |
| 2020 | -10.37x | ₩-47.71 Billion | ₩4.60 Billion | ₩52.31 Billion | ▼ -324.7% |
| 2018 | -2.44x | ₩-27.97 Billion | ₩11.45 Billion | ₩39.17 Billion | ▼ -439.1% |
| 2017 | 0.72x | ₩12.08 Billion | ₩16.76 Billion | ₩4.14 Billion | ▼ -46.2% |
| 2016 | 1.34x | ₩12.68 Billion | ₩9.47 Billion | ₩3.21 Billion | ▲ +22.0% |
| 2012 | 1.10x | ₩27.07 Billion | ₩24.65 Billion | ₩2.42 Billion | ▼ -5.1% |
| 2011 | 1.16x | ₩17.76 Billion | ₩15.34 Billion | ₩2.42 Billion | ▼ -0.9% |
| 2009 | 1.17x | ₩10.14 Billion | ₩8.68 Billion | ₩1.46 Billion | ▼ -13.1% |
| 2008 | 1.34x | ₩8.04 Billion | ₩5.99 Billion | ₩2.06 Billion | — |